A study to find a suitable dose of ASP5834 in adults with solid tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522082-29-00

Acronym

5834-CL-1001

Enrollment

Registered

2025-11-28

Start date

2026-01-16

Completion date

Unknown

Last updated

2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G12A, G12C, G12D, G12R or G13D mutation) or KRAS amplification, Locally advanced (unresectable) or metastatic solid tumor malignancies who harbor a KRAS mutation (G12V

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Spain

Outcome results